The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity
Open accessAbstract
Treatment with therapeutic proteins is an attractive approach to targeting a number of challenging diseases. Unfortunately, the native proteins themselves are often unstable in physiological conditions, reducing bioavailability and therefore increasing the dose that is required. Conjugation with poly(ethylene glycol) (PEG) is often used to increase stability, but this has a detrimental effect on bioactivity. Here, we introduce conjugation with zwitterionic polymers such as poly(carboxybetaine). We show that poly(carboxybetaine) conjugation improves stability in a manner similar to PEGylation, but that the new conjugates retain or even improve the binding affinity as a result of enhanced protein–substrate hydrophobic interactions. This chemistry opens a new avenue for the development of protein therapeutics by avoiding the need to compromise between stability and affinity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Jiang, S., & Cao, Z. (2010) · Advanced Materials · doi:10.1002/adma.200901407 · Cited by 2,027
Self-citationThe atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,964
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
Prime, K. L., & Whitesides, G. M. (1991) · Science · doi:10.1126/science.252.5009.1164 · Cited by 1,831
Peptide and protein PEGylation
Veronese, F. M. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00193-9 · Cited by 1,067
The Impact of PEGylation on Biological Therapies
Veronese, F. M., & Mero, A. (2008) · BioDrugs · doi:10.2165/00063030-200822050-00004 · Cited by 1,034
The Hofmeister series: salt and solvent effects on interfacial phenomena
CACACE, M. G., LANDAU, E. M., & RAMSDEN, J. J. (1997) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583597003363 · Cited by 1,005
PEGylation of therapeutic proteins
Jevševar, S., Kunstelj, M., & Porekar, V. G. (2010) · Biotechnology Journal · doi:10.1002/biot.200900218 · Cited by 681
PEGylated antibodies and antibody fragments for improved therapy: a review
Chapman, A. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00026-1 · Cited by 556
Pegram, L. M., & Record, M. T. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp070245z · Cited by 474
The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
Fishburn, C. S. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21278 · Cited by 474
Zhao, H. (2005) · Journal of Molecular Catalysis B: Enzymatic · doi:10.1016/j.molcatb.2005.08.007 · Cited by 389
Kosmotropes Form the Basis of Protein-Resistant Surfaces
Kane, R. S., Deschatelets, P., & Whitesides, G. M. (2003) · Langmuir · doi:10.1021/la020737x · Cited by 327
Site-specific PEGylation of native disulfide bonds in therapeutic proteins
Shaunak, S., Godwin, A., Choi, J.-W., Balan, S., Pedone, E., Vijayarangam, D., Heidelberger, S., Teo, I., Zloh, M., & Brocchini, S. (2006) · Nature Chemical Biology · doi:10.1038/nchembio786 · Cited by 261
Yang, W., Zhang, L., Wang, S., White, A. D., & Jiang, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.036 · Cited by 242
Self-citationCao, Z., Yu, Q., Xue, H., Cheng, G., & Jiang, S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200907079 · Cited by 215
Self-citationPolymers and proteins: interactions at interfaces
Szleifer, I. (1997) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(97)80125-8 · Cited by 207
Stabilization of α‐chymotrypsin upon PEGylation correlates with reduced structural dynamics
Rodríguez‐Martínez, J. A., Solá, R. J., Castillo, B., Cintrón‐Colón, H. R., Rivera‐Rivera, I., Barletta, G. L., & Griebenow, K. H. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22014 · Cited by 115
Treetharnmathurot, B., Ovartlarnporn, C., Wungsintaweekul, J., Duncan, R., & Wiwattanapatapee, R. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.016 · Cited by 104
Enzymatic activity and thermal stability of PEG-α-chymotrypsin conjugates
Rodríguez‐Martínez, J. A., Rivera‐Rivera, I., Solá, R. J., & Griebenow, K. H. (2009) · Biotechnology Letters · doi:10.1007/s10529-009-9947-y · Cited by 82
Cited by
Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D., & Chan, W. C. W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.020 · Cited by 1,349
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence
Chinen, A. B., Guan, C. M., Ferrer, J. R., Barnaby, S. N., Merkel, T. J., & Mirkin, C. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00321 · Cited by 1,032
Molecular Understanding and Design of Zwitterionic Materials
Shao, Q., & Jiang, S. (2015) · Advanced Materials · doi:10.1002/adma.201404059 · Cited by 908
Self-citation
Metadata
- Authors
- Keefe, A. J., & Jiang, S.
- Venue
- Nature Chemistry
- Published
- 2011-12-11
- Volume
- 4
- Issue
- 1
- Pages
- 59-63
- ISSN
- 1755-4330 (ISSN-L)
- 1755-4349
- OpenAlex
- W2009278211
- Cited by
- 576
- References
- 22
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.